| 发明名称 |
SURROGATE FUNCTIONAL DIAGNOSTICS TEST FOR CANCER |
| 摘要 |
The present invention relates to diagnostic methods that are relevant to various cancers and which comprise improvements on a BH3 profiling diagnostic method. |
| 申请公布号 |
US2015301053(A1) |
申请公布日期 |
2015.10.22 |
| 申请号 |
US201314440762 |
申请日期 |
2013.05.10 |
| 申请人 |
EUTROPICS PHARMACEUTICALS, INC. |
发明人 |
PIERCEALL William;CARDONE Michael H. |
| 分类号 |
G01N33/574;G01N21/64;G06F19/00 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for determining a cancer treatment for a patient, comprising:
determining a BH3 profile for the patient's tumor or cancer cell specimen; determining one or more clinical factors of the patient, and classifying the patient for likelihood of clinical response to one or more cancer treatments:
wherein the one or more clinical factors are selected to increase specificity and/or sensitivity of the BH3 profile for association with clinical response. |
| 地址 |
Cambridge MA US |
